NSG 552 - Psychopharmacology Exam #2 QUESTIONS AND ANSWERS
First-line treatment for PTSD - ANSWER SSRI
- Sertraline
- Citalopram
SNRI
- Venlafaxine
Neurological conditions that mimic/worsen anxiety symptoms (7) - ANSWER - Epilepsy
- Encephalitis
- Early dementia
- MS
- Migraine
- Meniere's
-Cerebrovascular disease
Stimulant FDA-approved for binge eating - ANSWER lisdexamfetamine (Vyvanse)
Considerations for patient with comorbid substance use and anxiety - ANSWER - Non-addictive
anxiolytic alternative (e.g., neurontin)
- Antihistamines with anxiolytic properties (e.g., Benadryl, hydroxyzine)
FDA-approved for bulimia - ANSWER Fluoxetine
Buspirone mechanism of action - ANSWER Partial agonist at 5HT-1A (decrease serotonergic activity)
, SSRIs - ANSWER May be helpful for patients with illness anxiety and comorbid anxiety/depressive
symptoms
Benzodiazepines recommended for patients with liver disease or alcoholism (3) - ANSWER - Oxazepam
- Temazepam
- Lorazepam
Clinical manifestations of benzodiazepine withdrawal (8) - ANSWER - Anxiety
- Anorexia
- Insomnia
- Irritability
- Hand tremors
- Autonomic hyperactivity (diaphoresis, tachycardia, HTN)
- Nausea, vomiting
- Tonic-clonic seizures
Antidepressants used for insomnia - ANSWER - Elaviol
- Doxepin
- Mirtazapine
- Trazodone
Modafinil - ANSWER First-line treatment for narcolepsy
Benzodiazepine mechanism of action - ANSWER Potentiate effects of GABA
Mood stabilizers used for RLS management - ANSWER - Gabapentin
First-line treatment for PTSD - ANSWER SSRI
- Sertraline
- Citalopram
SNRI
- Venlafaxine
Neurological conditions that mimic/worsen anxiety symptoms (7) - ANSWER - Epilepsy
- Encephalitis
- Early dementia
- MS
- Migraine
- Meniere's
-Cerebrovascular disease
Stimulant FDA-approved for binge eating - ANSWER lisdexamfetamine (Vyvanse)
Considerations for patient with comorbid substance use and anxiety - ANSWER - Non-addictive
anxiolytic alternative (e.g., neurontin)
- Antihistamines with anxiolytic properties (e.g., Benadryl, hydroxyzine)
FDA-approved for bulimia - ANSWER Fluoxetine
Buspirone mechanism of action - ANSWER Partial agonist at 5HT-1A (decrease serotonergic activity)
, SSRIs - ANSWER May be helpful for patients with illness anxiety and comorbid anxiety/depressive
symptoms
Benzodiazepines recommended for patients with liver disease or alcoholism (3) - ANSWER - Oxazepam
- Temazepam
- Lorazepam
Clinical manifestations of benzodiazepine withdrawal (8) - ANSWER - Anxiety
- Anorexia
- Insomnia
- Irritability
- Hand tremors
- Autonomic hyperactivity (diaphoresis, tachycardia, HTN)
- Nausea, vomiting
- Tonic-clonic seizures
Antidepressants used for insomnia - ANSWER - Elaviol
- Doxepin
- Mirtazapine
- Trazodone
Modafinil - ANSWER First-line treatment for narcolepsy
Benzodiazepine mechanism of action - ANSWER Potentiate effects of GABA
Mood stabilizers used for RLS management - ANSWER - Gabapentin
